October 5, 2011

Economists Give Cost-Benefit Analysis of HIV/AIDS Funding

A panel of the world’s premier economists—including three Nobel Laureates—presented findings on how to make funding most effective in the global fight against HIV/AIDS, Voice of America (VOA) reports. Assembled by project RethinkHIV, the expert panel in Washington, DC, offered a rigorous cost-benefit analysis of various HIV/AIDS prevention and treatment strategies to the Global Fund to Fight AIDS, Tuberculosis and Malaria. Key recommendations included spending more money on vaccine research, male circumcision programs and efforts to prevent mother-to-child transmission of HIV. If $100 million more is spent each year on developing an AIDS vaccine, the panel stated, it could speed the time it takes to develop a vaccine by as much as two years. The Copenhagen Consensus Center and the Rush Foundation sponsored the panel.

To read the VOA article, click here.

Search: economists, RethinkHIV, Nobel Laureates, cost-benefit, Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Fund, GF, AIDS vaccine, Copenhagen Consensus Center, Rush Foundation, male circumcision, mother-to-child

Scroll down to comment on this story.